Stocks to buy

Before we discuss the opportunity in Palantir (NYSE:PLTR) stock, we should spend a few minutes describing the landscape. The macroeconomic conditions are pretty bad, yet somehow the equity indices won’t stop making highs. The small caps exploded up 4% earlier this week in spite of a lot of negative headline littering the news feeds. That said,

I began writing about the hydrogen economy over a decade ago. Now the promise is real. Source: Shutterstock Plug Power (NASDAQ:PLUG), which produces fuel cell systems for short-haul transport, has announced a $1.5 billion investment from SK Group of Korea. The cash brings the Koreans about 10% of Plug Power. But it looks like good

Before I get into the details of the opportunity in Lemonade (NYSE:LMND), I want to talk about the entire market. LMND stock has a bright future, but  there’s a lot of extrinsic risk because, astonishingly, Wall Street is thriving while Main Street is struggling. Source: Stephanie L Sanchez / Shutterstock.com Mom-and-pop businesses are dying while larger

Bill Foley is really quite proud of his latest acquisition. His SPAC (special purpose acquisition company) uses his initials “BF” in the listed symbol for BFT stock, Foley Transimene Acquisition Corp II (NYSE:BFT). Source: Wright Studio / Shutterstock.com The presentation for the deal to combine with Paysafe, a U.K. fintech company, spends an inordinate amount

Many market participants often flock to the latest 13F filing for the wealthy and well-known investors as they become available each quarter. Investors are often anxious to see what the likes of Warren Buffet and others are buying and selling. While most of us will never know the kinds of wealth that these individuals have,

The Street ended the last month of the year on relatively firm footing. Now, many wonder if they should buy stocks at current levels. For retail investors, it’s next to impossible to time the market constantly. Yet, I believe with due diligence, it is possible to find stocks that will turbocharge portfolios in the new

As longtime readers know, I’m exceptionally bullish on electric vehicle stocks. But not all EV stocks are created equal. And one EV company that stands out from the rest in the best way possible is Canoo (NASDAQ:GOEV), which went public through a merger with Hennessey Capital Acquisition Corp. IV (NASDAQ:HCAC). Source: nrqemi / Shutterstock.com Here’s

While the stock market flopped to start 2021, shares of premium Chinese electric vehicle maker Nio (NYSE:NIO) did not. As of this writing, the S&P 500 is off about 2% in the first trading day of the New Year, while NIO stock is up about 10%. Source: Andy Feng / Shutterstock.com Why the surge in NIO

This year was full of firsts and I can’t wait to put an end to it today. The pandemic brought about a global reset button. We had to adapt and relearn many basic things we took for granted before the virus. In March when we shut down the world, I would have thought that stocks

Editor’s note: This column is part of our Best Stocks for 2020 contest. John Jagerson and Wade Hansen’s pick for the contest is Disney (NYSE:DIS). “Please keep your arms and hands inside the ride at all times…2020 is going to be a tumultuous year.” Source: by InvestorPlace That is how we started our write up

Everyone loves a good bargain, right? Well, when the market endured that painful selloff in March, it drove down stock valuations. At the time, though, volatility was so high and there were so many unknowns that it was hard to pile into names. So, are there still cheap stocks to buy now?  The short answer?

XPeng (NYSE:XPEV), the Chinese electric vehicle (EV) maker is up 100% in the last two months but it’s down 29% in the last month. That is due to the fact that XPEV stock peaked recently on Nov. 23 at $72.17. However, I believe XPEV stock is worth at least 100% more at $82 per share.

Editor’s note: This column is part of InvestorPlace.com’s Best Stocks for 2021 contest. Ben Reynolds’ pick for the contest is Walgreens Boots Alliance (NASDAQ:WBA). Walgreens Boots Alliance (NASDAQ:WBA) is a global pharmacy-led health enterprise, and WBA stock is one of the best to buy for 2021. Source: by InvestorPlace Overall, Walgreens is a large and

Editor’s note: This column is part of our Best Stocks for 2021 contest. The Readers’ Choice pick for the contest is Nio (NYSE:NIO). Source: by InvestorPlace Overall, 2020 has provided quite a ride for everyone. And as we look back at the past year, some of the best stocks on Wall Street emerged from the rubble of

The market’s fixation with drug manufacturers involved in treating or preventing the novel coronavirus is creating opportunities for value investors. Pfizer (NYSE:PFE), through its partnership with BioNTech SE (NASDAQ:BNTX), drew in investor interest. Between November and December, PFE stock traded no lower than $34 and topped around $43. Source: Manuel Esteban / Shutterstock.com Pfizer separated

2020 is almost over… Finally. What a year it’s been. It all started with a U.S. strike that killed Qasem Soleimani, the Commander of Iranian Forces, in January. Less than a month later, NBA legend Kobe Bryant died in a helicopter crash. Then, about a month after that, Tom Hanks tested positive for Covid-19, and

Of all my stock-picking mistakes in 2020, not getting on the Nio (NYSE:NIO) bandwagon and recommending NIO stock sooner is one of my biggest regrets.  Source: Robert Way / Shutterstock.com I waited until June to give the Chinese electric vehicle (EV) maker the thumbs up. In hindsight, once it got $1 billion in funding back

The World Health Organization estimates that 264 million people worldwide are impacted by depression. In a July 2020 survey, “53% of adults in the United States reported that their mental health has been negatively impacted due to worry and stress over the coronavirus.” With mental health becoming a bigger challenge, psychedelic stocks have been in

The future of healthcare will look so different that you may feel like you stepped into a new universe. From telemedicine to precision medicine to genetic therapy, the global healthcare industry is about to shake up like never before. Source: by InvestorPlace That said, one of the key pillars to getting there is genetic testing,

The race to produce an effective vaccine against the coronavirus put biotech firm, Moderna (NASDAQ:MRNA) on top of every investor’s watchlist. Moderna’s mRNA-1273 vaccine first received approval from the EUA and was closely followed by the FDA. The success of the vaccine and its swift authorization pushed MRNA stock by 600% this year. Source: Ascannio